|
|
| (3 intermediate revisions by the same user not shown) |
| Line 4: |
Line 4: |
| :* José Costa Teixeira | | :* José Costa Teixeira |
| :* Angela Merzweiler | | :* Angela Merzweiler |
| | :* Marc Robberecht |
| | :* Jacqueline Surugue |
|
| |
|
|
| |
|
| Line 9: |
Line 11: |
| :* Check the current state of the whitepaper | | :* Check the current state of the whitepaper |
| :* Decide next steps | | :* Decide next steps |
|
| |
|
| |
|
| =18:10 Whitepaper= | | =18:10 Whitepaper= |
|
| |
|
| :* Whitepaper can be found on | | :* Whitepaper can be found on |
| [ftp://iheyr2@ftp.ihe.net/Pharmacy/yr5_2013-2014/Technical_Committee/Whitepapers/DistributionAndSupplyOfItems/IHE_Pharmacy_White_Paper_Supply_Chain_Logistics_v0.8.doc] | | [ftp://ftp.ihe.net/Pharmacy/yr5_2013-2014/Technical_Committee/Whitepapers/DistributionAndSupplyOfItems/IHE_Pharmacy_White_Paper_Supply_Chain_Logistics_v0.8.doc ftp://ftp.ihe.net/Pharmacy/yr5_2013-2014/Technical_Committee/Whitepapers/DistributionAndSupplyOfItems/IHE_Pharmacy_White_Paper_Supply_Chain_Logistics_v0.8.doc] |
| | |
| | |
| | |
| | |
| [ftp://ftp.ihe.net/Pharmacy/yr6_2014-2015/Planning_Committee/Proposals/IHE_Profile_Proposal_MedicationTreatment_v1.docx ftp://ftp.ihe.net/Pharmacy/yr6_2014-2015/Planning_Committee/Proposals/IHE_Profile_Proposal_MedicationTreatment_v1.docx]
| |
| * Vision of the work ahead (Jürgen, Stephane)
| |
| :* [ftp://ftp.ihe.net/Pharmacy/yr6_2014-2015/Technical_Committee/Profiles/MedicationTherapy/MedicationTherapy%20Vision%2020141023.pptx ftp://ftp.ihe.net/Pharmacy/yr6_2014-2015/Technical_Committee/Profiles/MedicationTherapy/MedicationTherapy%20Vision%2020141023.pptx]
| |
| * Discussion
| |
| * '''Formal approval of the new work-item proposal'''
| |
| * Defining next steps
| |
| | |
| | |
| =10:45 - 11:00 Break=
| |
| | |
| | |
| =11:00 - 12:30 Pharmacy Administration=
| |
| * Current work:
| |
| :* [ftp://ftp.ihe.net/Pharmacy/yr6_2014-2015/Technical_Committee/Profiles/PharmacyAdministration ftp://ftp.ihe.net/Pharmacy/yr6_2014-2015/Technical_Committee/Profiles/PharmacyAdministration]
| |
| * Wrapping up work done so far, open issues and how to continue (Jürgen)
| |
| :* [ftp://ftp.ihe.net/Pharmacy/yr6_2014-2015/Technical_Committee/Profiles/PharmacyAdministration/Administration%20Issues%20and%20Thoughts%2020141023.pptx ftp://ftp.ihe.net/Pharmacy/yr6_2014-2015/Technical_Committee/Profiles/PharmacyAdministration/Administration%20Issues%20and%20Thoughts%2020141023.pptx]
| |
| * Discussion
| |
| * Defining next steps
| |
| | |
| | |
| =12:30 - 13:30 Lunch=
| |
| | |
| | |
| =13:30 - 14:00 Several Community Pharmacy related issues=
| |
| | |
| | |
| * PADV issue: Deep analysis of code "CHANGE" revealed that it actually means "CHANGE + OK" (= implies the OK too). Related to that, the state "OK" actually means "(Unchanged) OK"
| |
| :* Question: Do we need a simple "CHANGE" which does not also imply the OK? Not needed for A, SA and CH -> at the moment it is an academic discussion
| |
| | |
| * DIS issue: The Dispenser also needs Profession and Specialty
| |
| :* Proposal: Exchange <performer> by <author> for the Dispenser. Change <author> by a second <author> for a possible prescriber of the underlying prescription
| |
| | |
| * PADV issue: Requirement of CH: Providing comments to PRE or DIS items (e.g. The patient has problems swallowing the pill because it's too big).
| |
| :* Possible solution: Extend PADV by a new code "COMMENT", which has no effect on the workflow, but just provides commenting information, e.g. as concern
| |
| | |
| * PRE issue: Precondition is often used to describe dosage related information (e.g. "Take on demand")
| |
| :* Question: Shall it be moved under "Dosage instructions"?
| |
| | |
| * PADV, PML issue: The issue appears only, when a PRE entry is referenced in a PADV or embedded in a PML + this entry contains an internal reference in the "Reason" element (e.g. to a diagnosis expressed in an Active Problems section)
| |
| :* Current solution in PADV: The section referenced is not included and instructions are given how to break the internal reference
| |
| :* Proposed solution: CP on PADV and PML to allow 0..* additional sections to be added in order not to break the internal references. Those section do NOT belong to the PADV/PML document itself, but are just inserted to fulfill the internal reference
| |
| | |
| * PML issue: CH brought up that the PML might be used for "feeding" a medication plan
| |
| :* Discussion: Currently PML is intended as a "read-only", on-demand document. Shall that be changed? Should we add a note somewhere to clarify?
| |
| | |
| | |
| | |
| =14:00 - 15:15 ISO liaison=
| |
| * Report on ISO meeting in Berlin (Jürgen)
| |
| * Commenting on ISO/DIS 17523 "Requirements for electronic prescriptions"
| |
| :* [ftp://ftp.ihe.net/Pharmacy/yr6_2014-2015/Technical_Committee/Other/ISO%2017523%20ePrescriptions ftp://ftp.ihe.net/Pharmacy/yr6_2014-2015/Technical_Committee/Other/ISO%2017523%20ePrescriptions]
| |
| :* Comments received by Leonidas, Jose, Jürgen
| |
| :* Defining next steps
| |
| * ISO DTS 19293 "Requirements for the record of Dispense Medicinal Products"
| |
| :* Discussion
| |
| :* Defining next steps
| |
| * ISO/DTS 17251, "Business requirements for the exchange of structured dose instructions for medicinal products"
| |
| :* Discussion
| |
| :* Defining next steps
| |
| | |
| | |
| =15:15 - 15:30 Break=
| |
| | |
| | |
| =15:30 - 16:30 Hospital-Community Use Cases Whitepaper=
| |
| * Discussion
| |
| :* Can it be published? Open issues?
| |
| * Defining next steps
| |
| | |
| | |
| =16:30 - 17:00 Schedule=
| |
| * Current version:
| |
| :* [ftp://ftp.ihe.net/Pharmacy/yr6_2014-2015/Planning_Committee/Schedule/Schedule_2014-2015_v0.4.doc ftp://ftp.ihe.net/Pharmacy/yr6_2014-2015/Planning_Committee/Schedule/Schedule_2014-2015_v0.4.doc]
| |
| | |
| * Open issues:
| |
| :* Status of IHE Joint meeting with ITI, PCC and QRPH: 24-25 February 2015, ASIP Santé Offices, Paris, France (Jürgen)
| |
| :* Planning of dedicated technicel TCons to work-items (work-item leaders)
| |
|
| |
|
| | Conclusions: |
| | :* Whitepaper needs rework - reordering of the use cases, start with analytical, atomic use cases, and later explain the "orchestrated" end to end use cases. |
| | :* We should advance with the white paper before defining the profile. |
|
| |
|
| =17:00 Adjourn=
| | Next steps: |
| | :* Jose will start the rework of the white paper. Next version will be available for the next TCON |
| | :* Angela will share her model for the supply chain mechanisms. |
| | :* Proposal to make it bi-weekly. Accepted. |
| | :* Next tcon will be scheduled around the 27th of November. Jose will send a doodle asap. |
|
| |
|
| | =19:15 Adjourned= |
|
| |
|
| [[Pharmacy Planning Committee]]
| |
|
| |
|
| [[Category: Agenda]]
| | Discussion: |
18:00 - 19:00
- Simon Letellier
- José Costa Teixeira
- Angela Merzweiler
- Marc Robberecht
- Jacqueline Surugue
- Check the current state of the whitepaper
- Decide next steps
18:10 Whitepaper
- Whitepaper can be found on
ftp://ftp.ihe.net/Pharmacy/yr5_2013-2014/Technical_Committee/Whitepapers/DistributionAndSupplyOfItems/IHE_Pharmacy_White_Paper_Supply_Chain_Logistics_v0.8.doc
Conclusions:
- Whitepaper needs rework - reordering of the use cases, start with analytical, atomic use cases, and later explain the "orchestrated" end to end use cases.
- We should advance with the white paper before defining the profile.
Next steps:
- Jose will start the rework of the white paper. Next version will be available for the next TCON
- Angela will share her model for the supply chain mechanisms.
- Proposal to make it bi-weekly. Accepted.
- Next tcon will be scheduled around the 27th of November. Jose will send a doodle asap.
19:15 Adjourned
Discussion: